Benzoxathiole derivative blocks lipopolysaccharide-induced nuclear factor-kappaB activation and nuclear factor-kappaB-regulated gene transcription through inactivating inhibitory kappaB kinase beta. 2008

Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
College of Pharmacy, Chungbuk National University, Cheongju 361-763, Korea.

Benzoxathiole derivatives have been used in the treatment of acne and have shown cytostatic, antipsoriatic, and antibacterial properties. However, little is known about the molecular basis for these pharmacological properties, although nuclear factor (NF)-kappaB activation is closely linked to inflammation and cell proliferation. Here, we demonstrate that the novel small-molecule benzoxathiole 6,6-dimethyl-2-(phenylimino)-6,7-dihydro-5H-benzo-[1,3]oxathiol-4-one (BOT-64) inhibits NF-kappaB activation with an IC(50) value of 1 muM by blocking inhibitory kappaB(IkappaB) kinase beta (IKKbeta), and suppresses NF-kappaB-regulated expression of inflammatory genes in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages. BOT-64 inhibits IKKbeta-mediated IkappaBalpha phosphorylation in LPS-activated macrophages, resulting in sequential prevention of downstream events, including proteolytic degradation of IkappaBalpha, DNA binding ability, and transcriptional activity of NF-kappaB. BOT-64 inhibits LPS-inducible IKKbeta activity in the cells and catalytic activity of highly purified IKKbeta. Moreover, the effect of BOT-64 on cell-free IKKbeta was abolished by substitution of Ser-177 and Ser-181 residues in the activation loop of IKKbeta to glutamic acid residues, indicating a direct interaction site of benzoxathiole. BOT-64 attenuates NF-kappaB-regulated expression of inflammatory genes such as inducible nitric-oxide synthase, cyclooxygenase-2, tumor necrosis factor-alpha, interleukin (IL)-1beta, and IL-6 in LPS-activated or expression vector IKKbeta-transfected macrophages. Furthermore, BOT-64 dose-dependently increases the survival rates of endotoxin LPS-shocked mice.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D002384 Catalysis The facilitation of a chemical reaction by material (catalyst) that is not consumed by the reaction. Catalyses
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
July 2003, Molecular pharmacology,
Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
April 2002, American journal of respiratory and critical care medicine,
Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
August 2003, Anesthesiology,
Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
May 2010, Clinical and experimental immunology,
Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
February 2014, Current Alzheimer research,
Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
August 2006, Proceedings of the National Academy of Sciences of the United States of America,
Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
April 2007, Molecular immunology,
Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
June 2007, The Journal of biological chemistry,
Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
August 2004, The Journal of biological chemistry,
Byung Hak Kim, and Eunmiri Roh, and Hwa Young Lee, and In-Jeong Lee, and Byeongwoo Ahn, and Sang-Hun Jung, and Heesoon Lee, and Sang-Bae Han, and Youngsoo Kim
May 2010, Experimental & molecular medicine,
Copied contents to your clipboard!